217 Publications (Page 4 of 9)
2016
Phase II study of fosaprepitant+5HT3 receptor antagonist+dexamethasone in patients with germ cell tumors undergoing 5-day cisplatin-based chemotherapy: a Hoosier Cancer Research Network study
Adra, NabilAlbany, CostantineBrames, MaryCase-eads, SomerJohnson, CynthiaLiu, ZiyueFausel, ChristopherBreen, TimothyHanna, NasserHauke, RalphPicus, Joel and Einhorn, Lawrence
Supportive Care in Cancer, vol. 24, (no. 7), pp. 2837-2842, Jul 2016. | Journal Article
 
Phase II study of fosaprepitant + 5HT3 receptor antagonist + dexamethasone in patients with germ cell tumors undergoing 5-day cisplatin-based chemotherapy: a Hoosier Cancer Research Network study.
Adra, NabilAdra, NabilAlbany, CostantineAlbany, CostantineBrames, Mary JBrames, MaryCase-Eads, SomerCase-Eads, SomerJohnson, CynthiaJohnson, Cynthia SLiu, ZiyueLiu, ZiyueFausel, ChristopherFausel, Christopher ABreen, TimothyBreen, TimothyHanna, Nasser HHanna, NasserHauke, RalphHauke, Ralph JPicus, JoelPicus, JoelEinhorn, Lawrence H and Einhorn, Lawrence
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, vol. 24, (no. 7), pp. 2837-2842, July 2016. | Journal Article
 
Phase II trial of consolidation Pembrolizumab following concurrent chemoradiation in patients (pts) with unresectable or inoperable stage III non-small cell lung cancer (NSCLC): initial safety data from HCRN LUN 14-179
Durm, Greg AndrewDurm, Greg AndrewDurm, Greg AndrewKio, Ebenezer AKio, Ebenezer A.Kio, Ebenezer AFisher, William BFisher, William BFisher, William B.Titzer, Michael LTitzer, Michael L.Titzer, Michael LJabbour, SalmaJabbour, SalmaJabbour, SalmaBreen, TIMBreen, TIMBreen, TIMLiu, ZiyueLiu, ZiyueLiu, ZiyueHanna, Nasser HHanna, Nasser H and Hanna, Nasser H.
Journal of Clinical Oncology, vol. 34, (no. 15_suppl), pp. e20025, 2016-05-20. | Journal Article
 
Prognostic factors in patients with poor-risk germ-cell tumors: a retrospective analysis of the Indiana University experience from 1990 to 2014.
Adra, NAlthouse, S KLiu, HBrames, M JHanna, N HEinhorn, L H and Albany, C
Annals of oncology : official journal of the European Society for Medical Oncology, vol. 27, (no. 5), pp. 875-879, May 2016. | Journal Article
 
Randomized Pilot Trial of a Telephone Symptom Management Intervention for Symptomatic Lung Cancer Patients and Their Family Caregivers.
Mosher, Catherine E., PhDMosher, Catherine EWinger, Joseph G., MSWinger, Joseph GHanna, NasserHanna, Nasser, MDJalal, Shadia I., MDJalal, Shadia IEinhorn, Lawrence H., MDEinhorn, Lawrence HBirdas, Thomas J., MDBirdas, Thomas JCeppa, Duy Khanh PCeppa, DuyKhanh P., MDKesler, Kenneth A., MDKesler, Kenneth ASchmitt, JordanSchmitt, Jordan, MDKashy, Deborah AKashy, Deborah A., PhDChampion, Victoria and Champion, Victoria L
Journal of pain and symptom management, July 8, 2016. | Journal Article
 
Risk stratification of clinical stage I (CSI) non-seminomatous germ cell testicular tumors (NSGCT): A retrospective analysis of experience at Indiana University (IU)
Tatineni, SushmaTatineni, SushmaTatineni, SushmaDurm, Greg AndrewDurm, Greg AndrewDurm, Greg AndrewKunapareddy, Girish ChandraKunapareddy, Girish ChandraKunapareddy, Girish ChandraAmmakkanavar, Natraj ReddyAmmakkanavar, Natraj ReddyAmmakkanavar, Natraj ReddyDropcho, Edward FDropcho, Edward FDropcho, Edward FAlthouse, SandraAlthouse, SandraAlthouse, SandraHanna, Nasser HHanna, Nasser HHanna, Nasser HEinhorn, Lawrence HEinhorn, Lawrence HEinhorn, Lawrence HAlbany, CostantineAlbany, Costantine and Albany, Costantine
Journal of Clinical Oncology, vol. 34, (no. 15_suppl), pp. e16052, 2016-05-20. | Journal Article
 
Suggested reclassification strategy applied to intermediate and poor risk nonseminomatous germ cell tumors (NSGCT): A two-institution combined analysis
Necchi, AndreaNecchi, AndreaNecchi, AndreaPond, Gregory RussellPond, Gregory RussellPond, Gregory RussellNicolai, NicolaNicolai, NicolaNicolai, NicolaAdra, NabilAdra, NabilAdra, NabilGiannatempo, PatriziaGiannatempo, PatriziaGiannatempo, PatriziaRaggi, DanieleRaggi, DanieleRaggi, DanieleHanna, Nasser HHanna, Nasser HHanna, Nasser HSalvioni, RobertoSalvioni, RobertoSalvioni, RobertoEinhorn, Lawrence HEinhorn, Lawrence HEinhorn, Lawrence HAlbany, CostantineAlbany, Costantine and Albany, Costantine
Journal of Clinical Oncology, vol. 34, (no. 15_suppl), pp. 4546, 2016-05-20. | Journal Article
 
Survival outcomes of patients with metastatic germ cell tumor (mGCT) treated from 1998 to 2012: The Indiana University (IU) experience
Adra, NabilAdra, NabilAdra, NabilKu, Kimberly PeihsiKu, Kimberly PeihsiKu, Kimberly PeihsiKalra, MaitriKalra, MaitriKalra, MaitriAlthouse, SandraAlthouse, SandraAlthouse, SandraHanna, Nasser HHanna, Nasser HHanna, Nasser HEinhorn, Lawrence HEinhorn, Lawrence HEinhorn, Lawrence HAlbany, CostantineAlbany, Costantine and Albany, Costantine
Journal of Clinical Oncology, vol. 34, (no. 2_suppl), pp. 491, 2016-01-10. | Journal Article
2015
Adjuvant Epidermal Growth Factor Receptor Inhibitors in Non-Small Cell Lung Cancer.
Lourdes, Laura SJalal, Shadia I and Hanna, Nasser
(pp. 975-978). September 2015
 
An update on current standards and clinical trials in systemic therapy for stage III NSCLC
Durm, GregDurm, GregHanna, Nasser and Hanna, Nasser
Lung Cancer Management, vol. 4, (no. 6), pp. 297, 2015-December-01. | Journal Article
 
A randomized phase II study of the MEK1/MEK2 inhibitor trametinib (GSK1120212) compared with docetaxel in KRAS-mutant advanced non-small-cell lung cancer (NSCLC)†.
Blumenschein, G RSmit, E FPlanchard, DKim, D-WCadranel, JDe Pas, TDunphy, FUdud, KAhn, M-JHanna, N HKim, J-HMazieres, JKim, S-WBaas, PRappold, ERedhu, SPuski, AWu, F S and Jänne, P A
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO, vol. 26, (no. 5), pp. 894-901, May 2015. | Journal Article
 
A retrospective analysis of patients with metastatic germ cell tumor (GCT) treated at Indiana University (IU) from 2000 to 2012
Ku, KimberlyKu, KimberlyKu, KimberlyIbrahim, SamarIbrahim, SamarIbrahim, SamarAdra, NabilAdra, NabilAdra, NabilAlthouse, SandraAlthouse, SandraAlthouse, SandraHanna, Nasser HHanna, Nasser HHanna, Nasser HEinhorn, Lawrence HEinhorn, Lawrence HEinhorn, Lawrence HAlbany, CostantineAlbany, Costantine and Albany, Costantine
Journal of Clinical Oncology, vol. 33, (no. 15_suppl), pp. 4539, 2015-05-20. | Journal Article
 
Barriers to sperm banking in testicular cancer survivors
Sardesai, Sagar DSardesai, Sagar DSonnenburg, DanielSonnenburg, DanielHanna, NasserHanna, NasserBrames, Mary JBrames, Mary JCase-Eads, Sommer LeAnnCase-Eads, Sommer LeAnnEinhorn, Lawrence H and Einhorn, Lawrence H
Journal of Clinical Oncology, vol. 33, (no. 15_suppl), pp. e17574, 2015-05-20. | Journal Article
 
Coping with physical and psychological symptoms: a qualitative study of advanced lung cancer patients and their family caregivers.
Mosher, Catherine EMosher, CatherineMosher, CatherineMosher, CatherineMosher, CatherineOtt, MaryOtt, MaryOtt, MaryOtt, MaryOtt, Mary AHanna, NasserHanna, NasserHanna, NasserHanna, NasserHanna, NasserJalal, ShadiaJalal, ShadiaJalal, Shadia IJalal, ShadiaJalal, ShadiaChampion, VictoriaChampion, VictoriaChampion, VictoriaChampion, Victoria and Champion, Victoria L
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, vol. 23, (no. 7), pp. 2053-2060, July 2015. | Journal Article
 
Current Standards and Clinical Trials in Systemic Therapy for Stage III Lung Cancer: What Is New?
Hanna, Nasser
American Society of Clinical Oncology educational book / ASCO. American Society of Clinical Oncology. Meeting, pp. e442-e447, 2015. | Journal Article
 
Electronic nicotine delivery systems: a policy statement from the American Association for Cancer Research and the American Society of Clinical Oncology.
Brandon, Thomas HBrandon, Thomas HGoniewicz, Maciej LGoniewicz, Maciej LHanna, Nasser HHanna, Nasser HHatsukami, Dorothy KHatsukami, Dorothy KHerbst, Roy SHerbst, Roy SHobin, Jennifer AHobin, Jennifer AOstroff, Jamie SOstroff, Jamie SShields, Peter GShields, Peter GToll, Benjamin AToll, Benjamin ATyne, Courtney ATyne, Courtney AViswanath, KasisomayajulaViswanath, KasisomayajulaWarren, Graham W and Warren, Graham W
Clinical cancer research : an official journal of the American Association for Cancer Research, vol. 21, (no. 3), pp. 514-525, February 1, 2015. | Journal Article
 
Electronic nicotine delivery systems: a policy statement from the American Association for Cancer Research and the American Society of Clinical Oncology.
Brandon, Thomas HBrandon, Thomas HGoniewicz, Maciej LGoniewicz, Maciej LHanna, Nasser HHanna, Nasser HHatsukami, Dorothy KHatsukami, Dorothy KHerbst, Roy SHerbst, Roy SHobin, Jennifer AHobin, Jennifer AOstroff, Jamie SOstroff, Jamie SShields, Peter GShields, Peter GToll, Benjamin AToll, Benjamin ATyne, Courtney ATyne, Courtney AViswanath, KasisomayajulaViswanath, KasisomayajulaWarren, Graham W and Warren, Graham W
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, vol. 33, (no. 8), pp. 952-963, March 10, 2015. | Journal Article
 
Locally Advanced Non-Small Cell Lung Cancer: Optimal Chemotherapeutic Agents and Duration
Mamdani, HirvaJalal, Shadia and Hanna, Nasser
(pp. 1-11). Oct 2015
 
Lung cancer screening: what do long-term smokers know and believe?
Carter-Harris, LisaCarter-Harris, L.Ceppa, Duy Khanh PhamCeppa, D.P.Hanna, N.Hanna, NasserRawl, Susan M and Rawl, S.M.
Health expectations : an international journal of public participation in health care and health policy, December 23, 2015. | Journal Article
 
Phase II study of fosaprepitant +5HT3 receptor antagonist + dexamethasone in patients with germ cell tumors undergoing 5-day cisplatin-based chemotherapy: A Hoosier Cancer Research Network Study
Brames, Mary JBrames, Mary JCase-Eads, SomerCase-Eads, SomerHanna, Nasser HHanna, Nasser HFausel, Christopher AFausel, Christopher ABreen, TimothyBreen, TimothyEinhorn, Lawrence H and Einhorn, Lawrence H
Journal of Clinical Oncology, vol. 33, (no. 15_suppl), pp. e20737, 2015-05-20. | Journal Article
 
Prevalence of hypogonadism in patients with previously treated germ cell tumors
Miller, Trent JamesMiller, Trent JamesMiller, Trent JamesMiller, Trent JamesEinhorn, Lawrence HEinhorn, Lawrence HEinhorn, Lawrence HEinhorn, Lawrence HHanna, Nasser HHanna, Nasser HHanna, Nasser HHanna, Nasser HChampion, VictoriaChampion, VictoriaChampion, VictoriaChampion, VictoriaMonahan, PatrickMonahan, PatrickMonahan, PatrickMonahan, PatrickStump, Timothy EStump, Timothy EStump, Timothy EStump, Timothy EBrames, Mary JBrames, Mary JBrames, Mary JBrames, Mary JCase-Eads, SomerCase-Eads, SomerCase-Eads, Somer and Case-Eads, Somer
Journal of Clinical Oncology, vol. 33, (no. 15_suppl), pp. 9576, 2015-05-20. | Journal Article
 
Three-arm, randomized, phase 2 study of carboplatin and paclitaxel in combination with cetuximab, cixutumumab, or both for advanced non-small cell lung cancer (NSCLC) patients who will not receive bevacizumab-based therapy: An Eastern Cooperative Oncology Group (ECOG) study (E4508).
Hanna, Nasser HHanna, N.H.Dahlberg, S.E.Dahlberg, Suzanne EKolesar, J.M.Kolesar, Jill MAggarwal, CharuAggarwal, C.Hirsch, F.R.Hirsch, Fred RRamalingam, Suresh SRamalingam, S.S.Schiller, J.H. and Schiller, Joan H
Cancer, vol. 121, (no. 13), pp. 2253-2261, July 1, 2015. | Journal Article
 
Three-dimensional lymph node volume and craniocaudal lymph node length as an independent risk factor for recurrence or presence of micrometastatis in clinical stage I non-seminomatous germ cell tumors: A retrospective study
Maakaron, Joseph EMaakaron, Joseph EMaakaron, Joseph EGasparis, Pauley TGasparis, Pauley TGasparis, Pauley TAlthouse, SandraAlthouse, SandraAlthouse, SandraHanna, Nasser HHanna, Nasser HHanna, Nasser HEinhorn, Lawrence HEinhorn, Lawrence HEinhorn, Lawrence HCary, ClintCary, ClintCary, ClintAlbany, CostantineAlbany, CostantineAlbany, CostantineKohli, MarcKohli, Marc and Kohli, Marc
Journal of Clinical Oncology, vol. 33, (no. 15_suppl), pp. e15547, 2015-05-20. | Journal Article
2014
A randomized double-blind phase II trial of platinum (P) plus etoposide (E) with or without concurrent ZD6474 (Z) in patients (pts) with previously untreated extensive-stage (ES) small cell lung cancer (SCLC): Hoosier Oncology Group LUN06-113
Sanborn, Rachel ESanborn, Rachel EPatel, Jyoti DPatel, Jyoti DMasters, Gregory AMasters, Gregory AJayaram, NageshJayaram, NageshStephens, Anthony WStephens, Anthony WGuarino, Michael JGuarino, Michael JMisleh, Jamal GhaziMisleh, Jamal GhaziWilliams, Corinne EWilliams, Corinne EWu, JingweiWu, JingweiHanna, Nasser H and Hanna, Nasser H
Journal of Clinical Oncology, vol. 32, (no. 15_suppl), pp. 7506, 2014-05-20. | Journal Article
 
A retrospective analysis of patients with poor-risk germ cell tumor (PRGCT) treated at Indiana University from 1990 to 2011
Adra, NabilAdra, NabilAdra, NabilOza, AabhaOza, AabhaOza, AabhaAlbany, CostantineAlbany, CostantineAlbany, CostantineAlthouse, SandraAlthouse, SandraAlthouse, SandraHanna, Nasser HHanna, Nasser HHanna, Nasser HEinhorn, Lawrence HEinhorn, Lawrence H and Einhorn, Lawrence H
Journal of Clinical Oncology, vol. 32, (no. 15_suppl), pp. 4557, 2014-05-20. | Journal Article